Soleno Therapeutics (SLNO) has had the highest return since October 31, 2022 by a mid-cap US stock, returning 4,681.6%.
| ASSET | % RETURN |
|---|---|
Soleno Therapeutics (SLNO) | 4,681.55% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Regencell Bioscience (RGC) | 2,402.98% |
Dave (DAVE) | 1,893.74% |
Sezzle (SEZL) | 1,758.01% |
Cidara Therapeutics (CDTX) | 1,676.69% |
Powell Industries (POWL) | 1,252.28% |
Cipher Mining (CIFR) | 1,129.91% |
IES (IESC) | 1,071.13% |
IAMGold (IAG) | 1,047.86% |
Perpetua Resources (PPTA) | 1,031.58% |
Rigetti Computing (RGTI) | 980.29% |
Sterling Construction (STRL) | 952.99% |
Protagonist Therapeutics (PTGX) | 926.9% |
Terawulf (WULF) | 923.89% |
Celcuity LLC (CELC) | 889.51% |
Applied Digital (APLD) | 886.55% |
Abivax SA American Depositary Shares (ABVX) | 855.34% |
Tutor Perini (TPC) | 813.94% |
Argan (AGX) | 805.25% |
Praxis Precision Medicines (PRAX) | 804.29% |
New Gold (NGD) | 784.57% |
Olema Pharmaceuticals (OLMA) | 778.71% |
Eos Energy Enterprises (EOSE) | 764.08% |
Viking Therapeutics (VKTX) | 722.54% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
